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Rubinstein-Taybi syndrome associated 
with breast cancer — a case report
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Abstract
A number of cases of Rubinstein-Taybi Syndrome associated with different neoplastic lesions have been 
reported since this syndrome was first named in 1963. This paper reports a case of Rubinstein-Taybi Syn-
drome associated with breast cancer. Our aim is to share this finding and to emphasize how this case 
discussion allowed us to improve the management pathway in the future.
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Streszczenie
Od 1963 roku odnotowano szereg przypadków zespołu Rubinsteina-Taybiego związanych z różnymi zmia-
nami nowotworowymi. W poniższej pracy przedstawiono opis przypadku zespołu Rubinsteina-Taybiego 
związanego z nowotworem piersi. Celem pracy jest prezentacja wyników badań oraz ulepszenie zasad 
postępowania w podobnych przypadkach.
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Introduction
Rubinstein-Taybi syndrome (RSTS) is a rare congeni-
tal disease with mental disability and multiple physical 
anomalies. These include growth deficiency, abnormal 
morphology of thumbs and big toes [1]. Cardinal 
diagnostic signs include short stature, distinctive 
Craniofacial features as highly arched eyebrows, long 
eyelashes, down-slanting palpebral fissures, broad 
nasal bridge, beaked nose with the nasal septum 
extending well below the alae, highly arched palate, 
and mild micrognathia (fig.1). Also there is broad and 
duplicated distal phalanges of thumbs and halluces, 
and behavioural problems as moderate to severe 
intellectual disability (fig. 2. a, b). 
RSTS was initially reported by Greek orthopaedic 
surgeons Michail, Matsoukas and Theodorou from 
Athens, in 1957 [2–4], however, syndrome has been 
named after Jack Rubinstein, a paediatrician from 
Cincinnati (USA) & Hooshang Taybi, a paediatric radi-
ologist from Oklahoma (USA) who reported six RSTS 
cases in 1963 [5] . The name of Rubinstein-Taybi syn-
drome was definitively chosen by Warkany in 1974 [6].
It is known to be associated with some neoplasms, 
in this paper we report a female patient of RSTS asso-
ciated with breast cancer.
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disability, congestive cardiac failure, scoliosis, spina 
bifida, osteopenia and significant osteoporosis. Also 
she had a premature menopause.
Clinically in addition to classical features of RSTS 
as short stature, typical facial appearance, abnormally 
broad thumbs, significant mental retardation, hyper-
telorism (widely spaced eyes), a “beak-shaped” nose, 
broad nasal bridge and micrognathia (small lower jaw) 
with a small mouth opening and numerous carious 
lesions. There is large suspicious mass right breast ILQ 
(inner lower quadrant) of the right breast. Right breast 
ultrasound scan showed in the large irregular shaped 
hypoechoic solid lesion in ILQ, which has ill defined 
margins and which shows increased vascularity. The 
lesion measures 42 × 30 × 36 mm (24.4 cm3 volume). 
The appearance is of a malignancy and the finding 
graded as U5 using BIRADS [Breast Imaging-Reporting 
and Data System] (fig. 3). Ultrasound guided core bi-
opsy from the lesion revealed, Grade 2 invasive ductal 
carcinoma of the right breast, PR 8, ER 8, HER2 nega-
tive Ki67-55% (fig. 4).
Case report
A 52-years old lady presented with a recent history 
of right breast lump, noticed by the mother, who 
is the carer of this patient. She is a known case of 
Rubenstein-Taybi syndrome with sever psychomotor 
Figure 2. (a, b) Hands and feet in RSTS, Broad thumbs, 
broadened terminal phalanges, mild cutaneous syn-
dactyly between 3rd and 4th on the right and broad 
halluces (Hennekam 2006)
Figure 3. Right breast US revealing the pre-treatment 
tumour size of 42 mm 
Figure 4. Grade 2 invasive ductal carcinoma 
Figure 1. Typical facial features of Rubinstein-Taybi syn-
drome (Oliveria 2005)
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Discussion
RSTS is also known as broad thumb-hallux syn-
drome. It is an extremely rare condition, with a prev-
alence of one case per 125,000 live births [7].
It is inherited as an autosomal dominant pattern or 
sometimes as fresh sporadic genetic mutations. This 
is due to micro-deletion in the chromosomal region 
16p13.3 [8].
It is a genomic region encoding cyclic AMP re-
sponse element binding protein (CREB) binding pro-
tein (CBP). CBP is a transcriptional co-activator that 
binds to CREB when the latter is phosphorylated and 
promotes gene transcription [1] .
Also can be caused by mutation in gene E1A-bind-
ing protein (p300) [9].
RSTS is a multiple congenital anomaly syndrome. 
Cardinal diagnostic signs include short stature, distinc-
tive Craniofacial features, broad and duplicated distal 
phalanges of thumbs and halluces, and behavioural 
problems as well as moderate to severe intellectual 
disability. 
As mentioned earlier, the pathway of inheritance 
usually autosomal dominant, however, the patients 
with RSTS rarely reproduce [3].
This condition is associated with an increased risk 
of developing some neoplastic diseases as meningeo-
ma [9], neuroblastoma [10, 11], pheaochromocytoma 
[12], Rhabdomyosarcoma, leiomyosarcoma, semino-
ma, embryonal carcinoma [13] and leukemia [14].
As RSTS patients are prone to craniofacial devel-
opmental abnormalities, this will increase the risk of 
gastro-oesophageal reflux disease, (GERD) and con-
genital tracheal stenosis. This predisposed them to 
difficult intubation and airway compromisation [15]. 
There are some events during peri-operative period 
related to the anaesthesia as, intra-operative self-lim-
iting de-saturation, copious secretions causing airway 
compromise, arrhythmias and delayed recovery. All 
theses factors should be considered and thorough 
risk assessment should be performed to ensure the 
optimum care decision and choice [16].
This case has been discussed in the Breast Multidis-
ciplinary Team Meeting. In an ideal world she should 
have surgical excision of her tumour, however, due 
to high risks associated with general anaesthesia, 
the patient is treated with hormonal manipulation of 
tamoxifen only. A 12 months follow-up breast USG, 
showed a good response to the tamoxifen (fig. 5).
To our knowledge, no case of RSTS associated with 
breast cancer has been reported before.
Most women with a family history of breast cancer 
have alterations in particular genes, mainly BRCA1 and 
BRCA2, but also CHK2, ATM, STK11 and others. There 
are previous reports related to the genetic mutations 
seen in RSTS having an association with breast cancer.
Conclusion
RSTS association with breast cancer has not been 
reported before. Continuous observation and research 
is essential to explore this subject. Careful assessment 
needed with RSTS patients if general anaesthesia 
considered, this should cover craniofacial anomalies, 
airway anatomy, pulmonary function as well as cardi-
opulmonary status. If the patient is a high risk, then 
less invasive options should be considered.
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